Repligen Corporation
RGEN
$168.66
$2.351.41%
Headlines
5/3/2024
-
Simply Wall St
5/2/2024
-
Insider Monkey
5/2/2024
-
Zacks Investment Research
5/2/2024
-
Simply Wall St
5/2/2024
-
GuruFocus
5/2/2024
-
GuruFocus
5/1/2024
-
SeekingAlpha
5/1/2024
-
InvestorPlace
5/1/2024
-
GuruFocus
5/1/2024
-
Zacks Investment Research
5/1/2024
-
Ticker Report
5/1/2024
-
The Fly
5/1/2024
-
Globe Newswire
4/30/2024
-
Simply Wall St
4/26/2024
-
Zolmax
4/25/2024
-
Ticker Report
4/25/2024
-
Tickeron - Technical Analysis
4/25/2024
-
Zolmax
4/24/2024
-
Ticker Report
4/24/2024
-
Tickeron - Stocks
4/23/2024
-
Ticker Report
4/23/2024
-
Insider Monkey
4/23/2024
-
Zolmax
4/22/2024
-
Ticker Report
Filings
Thursday, February 22, 2024
Sunday, December 31, 2023
Beginning of May (est)
Price History
Corporate Info
781 250 0111
Building 1
Suite 100 - 41 Seyon Street
Waltham, MA 02453
Suite 100 - 41 Seyon Street
Waltham, MA 02453
Business Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and...
more